IRIS
NAPOLITANO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.353
EU - Europa 4.303
AS - Asia 3.778
SA - Sud America 394
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 13.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.301
CN - Cina 2.622
IE - Irlanda 1.110
UA - Ucraina 664
HK - Hong Kong 578
DE - Germania 495
RU - Federazione Russa 488
IT - Italia 409
SG - Singapore 402
FI - Finlandia 380
BR - Brasile 349
SE - Svezia 335
GB - Regno Unito 194
FR - Francia 139
CA - Canada 38
JP - Giappone 38
IN - India 24
MU - Mauritius 20
AR - Argentina 19
NL - Olanda 19
BE - Belgio 17
BD - Bangladesh 16
AT - Austria 15
ZA - Sudafrica 14
VN - Vietnam 12
MX - Messico 11
PK - Pakistan 11
ES - Italia 8
IQ - Iraq 8
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
IR - Iran 6
VE - Venezuela 6
EC - Ecuador 5
EU - Europa 5
JO - Giordania 5
MA - Marocco 5
PY - Paraguay 5
TR - Turchia 5
UZ - Uzbekistan 5
EG - Egitto 4
GE - Georgia 4
KZ - Kazakistan 4
PE - Perù 4
PT - Portogallo 4
SA - Arabia Saudita 4
TN - Tunisia 4
CO - Colombia 3
GR - Grecia 3
KE - Kenya 3
LV - Lettonia 3
NP - Nepal 3
PL - Polonia 3
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TW - Taiwan 2
BY - Bielorussia 1
CY - Cipro 1
ID - Indonesia 1
KW - Kuwait 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
TO - Tonga 1
UY - Uruguay 1
Totale 13.893
Salva come PNG Salva come JPEG
Città #
Dublin 1.110
Chandler 1.040
Jacksonville 854
Nanjing 716
Hong Kong 577
Boardman 371
Ashburn 366
Beijing 322
Nanchang 301
Princeton 259
Lawrence 233
Wilmington 222
Hebei 219
Changsha 187
Shenyang 183
Singapore 172
Jiaxing 151
Medford 148
Helsinki 121
Tianjin 117
Shanghai 104
Moscow 102
Milan 90
Hangzhou 86
Woodbridge 82
San Genesio Ed Uniti 69
New York 65
Ann Arbor 63
Norwalk 47
Falls Church 45
Falkenstein 44
Verona 42
The Dalles 38
Los Angeles 37
Munich 37
Seattle 35
São Paulo 31
Chicago 30
Tokyo 30
Nuremberg 29
Pavia 27
Des Moines 25
Houston 22
Fairfield 19
Kunming 19
Columbus 18
Zhengzhou 18
Brussels 17
San Francisco 16
Toronto 15
Jinan 14
Washington 14
Dallas 12
Ningbo 12
Tappahannock 11
Brooklyn 10
Dearborn 10
Santa Clara 10
Changchun 9
Düsseldorf 9
Guangzhou 9
Naples 9
Palermo 9
Rome 9
Taizhou 9
Turku 9
London 8
Rio de Janeiro 8
Auburn Hills 7
Dhaka 7
Orange 7
Brasília 6
Johannesburg 6
Mexico City 6
Montreal 6
Phoenix 6
Pune 6
Salvador 6
Somma Lombardo 6
Belo Horizonte 5
Borås 5
Frankfurt am Main 5
Ho Chi Minh City 5
Kobe 5
Lanzhou 5
Lauterbourg 5
Monza 5
Piscataway 5
Portsmouth 5
São Bernardo do Campo 5
São José dos Pinhais 5
Tashkent 5
Zola Predosa 5
Alghero 4
Alvorada 4
Amman 4
Buenos Aires 4
Castel Volturno 4
Curitiba 4
Genoa 4
Totale 9.319
Salva come PNG Salva come JPEG
Nome #
Tachicardia Ventricolare Polimorfa Catecolaminergica 142
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 133
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 125
A method of gene transfer for the treatment of recessive CPVT 122
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 105
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 102
Gene-specific therapy for inherited arrhythmogenic diseases 92
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 92
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 90
Patient-tailored Workflow Patterns from Clinical Practice Guidelines Recommendations. 89
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 89
Computer simulation of wild-type and mutant human cardiac Na+ current 88
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 88
Risk stratification in the Long-QT Syndrome 87
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 86
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 86
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 86
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 83
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 82
Cardiac Sodium Channel Diseases 81
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 81
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 80
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 80
Interplay between Clinical Guidelines and Organizational Workflow Systems. Experience from the MobiGuide project 79
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 78
Combining decision support system-generated recommendations with interactive guideline visualization for better informed decisions 78
Assessment of a personalized and distributed patient guidance system 78
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 78
Information extraction from Italian medical reports: An ontology-driven approach 78
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 77
Evaluation of BLS-D training in lay people. 76
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 76
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 75
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 75
Inherited arrhythmia: present and future perspectives for genetic therapy 74
R Engine Cell: integrating R into the i2b2 software infrastructure. 74
Supporting shared decision making within the MobiGuide project. 74
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 73
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 73
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 73
Genetics of ion-channel disorders 73
A Recessive Variant of the Romano-Ward Long QT Syndrome 72
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 72
The long QT syndrome 72
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 72
“Cardiac Risk Stratification by NOS1AP Genotyping” 71
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 71
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 70
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 70
Timothy Syndrome 70
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? 70
L-TYPE CALCIUM CHANNEL DISEASE 70
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 70
[Computerized tomography study of 32 patients with disk hernia confirmed during surgical intervention]. 70
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 70
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 69
BRUGADA SYNDROME AND CONDUCTION SYSTEM DISEASE ARE LINKED TO A SINGLE SODIUM CHANNEL MUTATION. 69
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism 69
Brugada syndrome 69
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 68
MobiGuide: a personalized and patient-centric decision-support system and its evaluation in the atrial fibrillation and gestational diabetes domains 68
Molecular underpinning of ''good luck'' 67
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 67
Inherited calcium channelopathies in the pathophysiology of arrhythmias. 67
A molecular basis for the therapy of the long QT syndrome 67
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 67
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 67
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 66
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model 66
Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias 66
Genetics of Arrhythmogenic Disorders 66
RyRCa Leak Limits Cardiac Ca Windows Current Overcoming the Tonic Effect of Calmodulin Mice. 66
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 66
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 66
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers 66
Experimental Therapy of genetic arrhythmias: disease-specific pharmacology. 65
Long QT Syndrome 65
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation 65
Evaluation of spatial aspects of T-wave complexity in the Long QT syndrome 65
Information Extraction from Italian medical reports: first steps towards clinical timelines development 65
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 65
Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. 64
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. 64
Patient-tailored workflow patterns from clinical practice guidelines recommendations 64
Novel Arrhythmogenic mechanism revealed by Long-QT Syndrome mutation in the Cardiac NA+ Channel 64
[Role of standard resting ECG in the assessment of sudden cardiac death risk] 64
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients 64
Clinical timelines development from textual medical reports in Italian 64
Clinical and research data integration: the i2b2-FSM experience 63
Letter regarding article by Coronel et al, ''right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study'' 62
In the RyR2R4496C Mouse Model of CPVT, {beta}-Adrenergic Stimulation Induces Ca Waves by Increasing SR Ca Content and Not by Decreasing the Threshold for Ca Waves. 62
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age 62
Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes 62
Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor (RyR2) 62
Low penetrance mutations and compound heterozygosity in LQTS: phenotypic consequences and implications for the clinical presentation of the disease 62
Long QT syndrome in adults. 62
Genetic of Long QT, Brugada and Other Channelopathies 61
Genetic and molecular basis of arrhythmias. 61
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. 61
Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk Profiling 61
Totale 7.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.307 144 125 44 123 2 175 10 186 77 196 171 54
2021/20221.003 8 2 16 6 27 55 34 59 82 51 155 508
2022/20233.090 363 193 42 260 289 350 2 146 1.298 18 78 51
2023/20241.169 137 175 55 103 107 315 53 63 5 24 36 96
2024/20253.129 58 271 68 88 78 155 191 286 717 128 288 801
2025/2026145 145 0 0 0 0 0 0 0 0 0 0 0
Totale 14.065